Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation
. 1996 May 1;183(5):2143-52.
doi: 10.1084/jem.183.5.2143.

Development of insulitis without diabetes in transgenic mice lacking perforin-dependent cytotoxicity

Affiliations

Development of insulitis without diabetes in transgenic mice lacking perforin-dependent cytotoxicity

D Kägi et al. J Exp Med. .

Abstract

It is widely accepted that T cells play an important role in the destruction of beta cells leading to autoimmune type I diabetes, but the involved effector mechanisms have remained unclear. We addressed this issue by testing the role of perforin-dependent cytotoxicity in a disease model involving transgenic mice expressing glycoprotein of lymphocytic choriomeningitis virus (LCMV-GP) in the beta cells of the endocrine pancreas. In such mice, LCMV infection leads to a potent LCMV-GP-specific T cell response resulting in rapid development of diabetes. We report here that in perforin-deficient LCMV-GP transgenic mice, LCMV infection failed to induce diabetes despite the activation of LCMV-GP-specific T cells. Deletion of nu beta 6+ T cells in Mls-1a perforin-deficient mice and the activation of LCMV-GP-specific T cells in perforin-deficient LCMV-GP transgenic mice, however, indicated that thymic tolerance induction by negative selection was not affected by the disruption of the perforin gene and that there is no fundamental difference between the T cell repertoires of normal control and perforin-deficient mice. In addition, adoptive transfer of LCMV-GP-specific TCR transgenic perforin-deficient T cells activated by LCMV-GP recombinant vaccinia virus led to marked insulitis with infiltration of CD4+ and CD8+ T cells without the development of diabetes. These findings indicate that perforin-dependent cytotoxicity is not required for the initiation of insulitis but is crucial for the destruction of beta cells in the later phase of the disease process. Other mechanisms or soluble factors present in the inflammatory islet infiltrate apparently lack the ability to efficiently induce diabetogenic beta cell damage.

PubMed Disclaimer

Similar articles

Cited by

  • Requirement of Fas for the development of autoimmune diabetes in nonobese diabetic mice.
    Itoh N, Imagawa A, Hanafusa T, Waguri M, Yamamoto K, Iwahashi H, Moriwaki M, Nakajima H, Miyagawa J, Namba M, Makino S, Nagata S, Kono N, Matsuzawa Y. Itoh N, et al. J Exp Med. 1997 Aug 18;186(4):613-8. doi: 10.1084/jem.186.4.613. J Exp Med. 1997. PMID: 9254659 Free PMC article.
  • Dendritic cells induce autoimmune diabetes and maintain disease via de novo formation of local lymphoid tissue.
    Ludewig B, Odermatt B, Landmann S, Hengartner H, Zinkernagel RM. Ludewig B, et al. J Exp Med. 1998 Oct 19;188(8):1493-501. doi: 10.1084/jem.188.8.1493. J Exp Med. 1998. PMID: 9782126 Free PMC article.
  • A mouse CD8 T cell-mediated acute autoimmune diabetes independent of the perforin and Fas cytotoxic pathways: possible role of membrane TNF.
    Herrera PL, Harlan DM, Vassalli P. Herrera PL, et al. Proc Natl Acad Sci U S A. 2000 Jan 4;97(1):279-84. doi: 10.1073/pnas.97.1.279. Proc Natl Acad Sci U S A. 2000. PMID: 10618409 Free PMC article.
  • Effector lymphocytes in islet cell autoimmunity.
    Santamaria P. Santamaria P. Rev Endocr Metab Disord. 2003 Sep;4(3):271-80. doi: 10.1023/a:1025156413404. Rev Endocr Metab Disord. 2003. PMID: 14501178 Review. No abstract available.
  • Guidelines for the use of flow cytometry and cell sorting in immunological studies (second edition).
    Cossarizza A, Chang HD, Radbruch A, Acs A, Adam D, Adam-Klages S, Agace WW, Aghaeepour N, Akdis M, Allez M, Almeida LN, Alvisi G, Anderson G, Andrä I, Annunziato F, Anselmo A, Bacher P, Baldari CT, Bari S, Barnaba V, Barros-Martins J, Battistini L, Bauer W, Baumgart S, Baumgarth N, Baumjohann D, Baying B, Bebawy M, Becher B, Beisker W, Benes V, Beyaert R, Blanco A, Boardman DA, Bogdan C, Borger JG, Borsellino G, Boulais PE, Bradford JA, Brenner D, Brinkman RR, Brooks AES, Busch DH, Büscher M, Bushnell TP, Calzetti F, Cameron G, Cammarata I, Cao X, Cardell SL, Casola S, Cassatella MA, Cavani A, Celada A, Chatenoud L, Chattopadhyay PK, Chow S, Christakou E, Čičin-Šain L, Clerici M, Colombo FS, Cook L, Cooke A, Cooper AM, Corbett AJ, Cosma A, Cosmi L, Coulie PG, Cumano A, Cvetkovic L, Dang VD, Dang-Heine C, Davey MS, Davies D, De Biasi S, Del Zotto G, Dela Cruz GV, Delacher M, Della Bella S, Dellabona P, Deniz G, Dessing M, Di Santo JP, Diefenbach A, Dieli F, Dolf A, Dörner T, Dress RJ, Dudziak D, Dustin M, Dutertre CA, Ebner F, Eckle SBG, Edinger M, Eede P, Ehrhardt GRA, Eich M, Engel P, Engelhardt B, Erdei A, Esser C, Everts B, Evrard M, Falk CS, Fehniger TA, Felipo-Benavent M, Fer… See abstract for full author list ➔ Cossarizza A, et al. Eur J Immunol. 2019 Oct;49(10):1457-1973. doi: 10.1002/eji.201970107. Eur J Immunol. 2019. PMID: 31633216 Free PMC article.

References

    1. Eur J Immunol. 1981 Oct;11(10):805-15 - PubMed
    1. Nature. 1989 Nov 30;342(6249):559-61 - PubMed
    1. Nature. 1984 Dec 6-12;312(5994):548-51 - PubMed
    1. N Engl J Med. 1985 Aug 8;313(6):353-60 - PubMed
    1. J Immunol. 1989 Dec 15;143(12):3994-9 - PubMed

Publication types

MeSH terms